₹2505.35*
MRP ₹3055.3
18% off
₹2597*
MRP ₹3055.3
15% CB
₹458.3 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Available Offers
PHARMA1818% OFF, applicable on orders > INR 2999
PHARMA1010% OFF, applicable on orders > INR 799
PHARMA2020% OFF, applicable on orders > INR 5499
Prescription drugWhats That
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Extra Savings
Composition :
IBANDRONIC ACID-1MG
Manufacturer/Marketer :
Sun Pharmaceutical Industries Ltd
Consume Type :
PARENTERAL
Return Policy :
3 Days Returnable
Expires on or after :
Jan-27
Drug-Drug Interactions
Ibandronic acidIohexol
Severe
Ibandronic acidDeferasirox
Severe
Drug-Drug Interactions
Login/Sign Up
Ibandronic acidIohexol
Severe
How does the drug interact with Idrofos 1 mg/ml Infusion 6 ml:
Co-administration of Iohexol with Idrofos 1 mg/ml Infusion 6 ml may increase the risk of kidney damage.
How to manage the interaction:
There may be a possibility of interaction between Idrofos 1 mg/ml Infusion 6 ml and Iohexol, but it can be taken if prescribed by a doctor. However, contact a doctor immediately if you experience any symptoms such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Do not discontinue any medications without consulting a doctor.
Co-administration of Iohexol with Idrofos 1 mg/ml Infusion 6 ml may increase the risk of kidney damage.
How to manage the interaction:
There may be a possibility of interaction between Idrofos 1 mg/ml Infusion 6 ml and Iohexol, but it can be taken if prescribed by a doctor. However, contact a doctor immediately if you experience any symptoms such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Do not discontinue any medications without consulting a doctor.
Ibandronic acidDeferasirox
Severe
How does the drug interact with Idrofos 1 mg/ml Infusion 6 ml:
Co-administration of Deferasirox with Idrofos 1 mg/ml Infusion 6 ml (oral form) may raise your chance of experiencing gastrointestinal (stomach & intestine) bleeding and ulcers.
How to manage the interaction:
Co-administration of Idrofos 1 mg/ml Infusion 6 ml with Deferasirox can result in an interaction, but it can be taken if a doctor has advised it. If you have symptoms like stomach pain, bloating, dizziness, or black stools, it's essential to consult a doctor. Do not stop using any medications without a doctor's advice.
Co-administration of Deferasirox with Idrofos 1 mg/ml Infusion 6 ml (oral form) may raise your chance of experiencing gastrointestinal (stomach & intestine) bleeding and ulcers.
How to manage the interaction:
Co-administration of Idrofos 1 mg/ml Infusion 6 ml with Deferasirox can result in an interaction, but it can be taken if a doctor has advised it. If you have symptoms like stomach pain, bloating, dizziness, or black stools, it's essential to consult a doctor. Do not stop using any medications without a doctor's advice.
Ibandronic acidMetrizamide
Severe
How does the drug interact with Idrofos 1 mg/ml Infusion 6 ml:
Co-administration of Metrizamide with Idrofos 1 mg/ml Infusion 6 ml may increase the risk or severity of kidney damage
How to manage the interaction:
Taking Idrofos 1 mg/ml Infusion 6 ml with Metrizamide together can result in an interaction, but it can be taken if a doctor has advised it. However, consult a doctor immediately if you experience any symptoms such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Do not discontinue any medications without consulting a doctor.
Co-administration of Metrizamide with Idrofos 1 mg/ml Infusion 6 ml may increase the risk or severity of kidney damage
How to manage the interaction:
Taking Idrofos 1 mg/ml Infusion 6 ml with Metrizamide together can result in an interaction, but it can be taken if a doctor has advised it. However, consult a doctor immediately if you experience any symptoms such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Do not discontinue any medications without consulting a doctor.
Ibandronic acidTacrolimus
Severe
How does the drug interact with Idrofos 1 mg/ml Infusion 6 ml:
Taking Tacrolimus and Idrofos 1 mg/ml Infusion 6 ml together may increase the risk of kidney problems.
How to manage the interaction:
Although taking Tacrolimus and Idrofos 1 mg/ml Infusion 6 ml together can result in an interaction, it can be taken if a doctor has prescribed it. However, consult the doctor immediately if you experience symptoms such as nausea, vomiting, loss of hunger, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Do not discontinue any medications without consulting a doctor.
Taking Tacrolimus and Idrofos 1 mg/ml Infusion 6 ml together may increase the risk of kidney problems.
How to manage the interaction:
Although taking Tacrolimus and Idrofos 1 mg/ml Infusion 6 ml together can result in an interaction, it can be taken if a doctor has prescribed it. However, consult the doctor immediately if you experience symptoms such as nausea, vomiting, loss of hunger, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Do not discontinue any medications without consulting a doctor.
Ibandronic acidHuman immunoglobulin
Severe
How does the drug interact with Idrofos 1 mg/ml Infusion 6 ml:
Co-administration of Human immunoglobulin with Idrofos 1 mg/ml Infusion 6 ml may raise the risk of kidney problems.
How to manage the interaction:
Although there is a possible interaction between Human immunoglobulin and Idrofos 1 mg/ml Infusion 6 ml, you can take these medicines together if prescribed by a doctor. However, if you experience nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, or an irregular heart rhythm, consult a doctor. Do not discontinue any medications without consulting a doctor.
Co-administration of Human immunoglobulin with Idrofos 1 mg/ml Infusion 6 ml may raise the risk of kidney problems.
How to manage the interaction:
Although there is a possible interaction between Human immunoglobulin and Idrofos 1 mg/ml Infusion 6 ml, you can take these medicines together if prescribed by a doctor. However, if you experience nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, or an irregular heart rhythm, consult a doctor. Do not discontinue any medications without consulting a doctor.
Ibandronic acidTenofovir alafenamide
Severe
How does the drug interact with Idrofos 1 mg/ml Infusion 6 ml:
Co-administration of Tenofovir alafenamide with Idrofos 1 mg/ml Infusion 6 ml can increase the risk of kidney damage.
How to manage the interaction:
Taking Idrofos 1 mg/ml Infusion 6 ml with Tenofovir alafenamide together can result in an interaction, but it can be taken if a doctor has advised it. However, if you experience symptoms such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, pain in the muscles, weakness, tiredness, dizziness, confusion, and irregular heart rhythm, consult a doctor. Do not stop using any medications without consulting a doctor.
Co-administration of Tenofovir alafenamide with Idrofos 1 mg/ml Infusion 6 ml can increase the risk of kidney damage.
How to manage the interaction:
Taking Idrofos 1 mg/ml Infusion 6 ml with Tenofovir alafenamide together can result in an interaction, but it can be taken if a doctor has advised it. However, if you experience symptoms such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, pain in the muscles, weakness, tiredness, dizziness, confusion, and irregular heart rhythm, consult a doctor. Do not stop using any medications without consulting a doctor.
Ibandronic acidSirolimus
Severe
How does the drug interact with Idrofos 1 mg/ml Infusion 6 ml:
Co-administration of Sirolimus and Idrofos 1 mg/ml Infusion 6 ml may cause an increase in the risk or severity of kidney damage.
How to manage the interaction:
Although taking Idrofos 1 mg/ml Infusion 6 ml and Sirolimus together may lead to an interaction, it can be taken if a doctor has suggested it. However, if you experience symptoms such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, pain in the muscles, weakness, tiredness, dizziness, confusion, and irregular heart rhythm, consult a doctor. Do not stop using any medication without consulting a doctor.
Co-administration of Sirolimus and Idrofos 1 mg/ml Infusion 6 ml may cause an increase in the risk or severity of kidney damage.
How to manage the interaction:
Although taking Idrofos 1 mg/ml Infusion 6 ml and Sirolimus together may lead to an interaction, it can be taken if a doctor has suggested it. However, if you experience symptoms such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, pain in the muscles, weakness, tiredness, dizziness, confusion, and irregular heart rhythm, consult a doctor. Do not stop using any medication without consulting a doctor.
Ibandronic acidCidofovir
Severe
How does the drug interact with Idrofos 1 mg/ml Infusion 6 ml:
Co-administration of Cidofovir with Idrofos 1 mg/ml Infusion 6 ml can increase the risk of kidney problems.
How to manage the interaction:
Although taking Idrofos 1 mg/ml Infusion 6 ml and Cidofovir together can cause an interaction, it can be taken if your doctor has suggested it. However, if you experience nausea, vomiting, loss of hunger, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, or an irregular heart rhythm, consult a doctor. Do not discontinue any medications without consulting a doctor.
Co-administration of Cidofovir with Idrofos 1 mg/ml Infusion 6 ml can increase the risk of kidney problems.
How to manage the interaction:
Although taking Idrofos 1 mg/ml Infusion 6 ml and Cidofovir together can cause an interaction, it can be taken if your doctor has suggested it. However, if you experience nausea, vomiting, loss of hunger, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, or an irregular heart rhythm, consult a doctor. Do not discontinue any medications without consulting a doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Idrofos 1 mg/ml Infusion 6 ml Substitute
BONIMET 6MG INJECTION 6ML
₹369.41per tablet
Product Substitutes
Alcohol
Caution
It is not known if alcohol affects Idrofos 1 mg/ml Infusion 6 ml. Please consult your doctor.
Pregnancy
Caution
Idrofos 1 mg/ml Infusion 6 ml is indicated for use in postmenopausal women. Consult your doctor if you are pregnant. Your doctor will prescribe Idrofos 1 mg/ml Infusion 6 ml only if the benefits outweigh the risks.
Breast Feeding
Caution
It is not known if Idrofos 1 mg/ml Infusion 6 ml passes into breast milk. Inform your doctor before taking this medicine if you are breastfeeding.
Driving
Safe if prescribed
Idrofos 1 mg/ml Infusion 6 ml has no or negligible influence on the ability to drive.
Liver
Caution
Please consult your doctor if you have a liver impairment or any concerns regarding this.
Kidney
Caution
Idrofos 1 mg/ml Infusion 6 ml is not recommended for people with severe renal impairment. Please consult your doctor if you have kidney impairment or any concerns regarding this.
Children
Unsafe
Idrofos 1 mg/ml Infusion 6 ml is not recommended for children as safety and effectiveness have not been established.
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
